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Glioblastoma (GB) is the most frequent and aggressive type of primary brain tumor.
Recurrences are mostly located at the margin of the resection cavity in the
peritumoral brain zone (PBZ). Although it is widely believed that infiltrative tumor
cells in this zone are responsible for GB recurrence, few studies have examined this
zone. In this study, we analyzed PBZ left after surgery with a variety of techniques
including radiology, histopathology, flow cytometry, genomic, transcriptomic,
proteomic, and primary cell cultures. The resulting PBZ profiles were compared
with those of the GB tumor zone and normal brain samples to identify
characteristics specific to the PBZ. We found that tumor cell infiltration detected by
standard histological analysis was present in almost one third of PBZ taken from an
area that was considered normal both on standard MRI and by the neurosurgeon
under an operating microscope. The panel of techniques used in this study show
that the PBZ, similar to the tumor zone itself, is characterized by substantial inter-
patient heterogeneity, which makes it difficult to identify representative markers.
Nevertheless, we identified specific alterations in the PBZ such as the presence of
selected tumor clones and stromal cells with tumorigenic and angiogenic properties.
The study of GB-PBZ is a growing field of interest and this region needs to be
characterized further. This will facilitate the development of new, targeted therapies
for patients with GB and the development of approaches to refine the per-operative
evaluation of the PBZ to optimize the surgical resection of the tumor.
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